Indian Equities Fall Amid Geopolitical Uncertainty And Multiple Corporate Updates

Indian equities fell sharply on Monday, with the Nifty 50 down 1.56% to 22,780.25 amid geopolitical uncertainty and rising crude prices; analysts put near-term support at 22,650–22,700. SAIL and Bharat Coking Coal agreed to jointly develop two coal blocks in West Bengal, while Power Grid approved up to ₹10,000 crore in SBI borrowing and won a Maharashtra transmission project. Rashtriya Chemicals and Fertilizers awarded Larsen & Toubro a ₹797 crore ammonia-plant revamp order and received approval to raise up to ₹1,500 crore through an FPO; Godrej Properties announced a Marine Lines project with estimated revenue potential of about ₹6,000 crore, and NMDC commissioned a 2-million-tonne-a-year pellet plant. Other announcements included NCC’s ₹1,076.71 crore water-supply order, Ellenbarrie’s ₹481 crore BHEL contract, JSW Energy’s turbine-generator order, Balrampur Chini Mills’ ₹75 crore PLA research grant and IRFC’s ₹4,200 crore loan agreement with DVC. Zydus Lifesciences reported one observation, with none related to data integrity, following a USFDA inspection; ITC made Sproutlife Foods a wholly owned subsidiary. SAIL and LIC Housing Finance were scheduled to be barred from F&O trading on September 29.
Varmora Granito was set to list on the stock exchanges after its IPO was subscribed 1.42 times; investors bid for 1.85 crore shares against 1.30 crore shares on offer.
Prasol Chemicals reported a 150.7% year-on-year rise in Q1 FY27 consolidated net profit to ₹61 crore, while revenue from operations grew 35.7% to ₹433.6 crore.
HCL Software said it intends to acquire Croatia-based Robotiq.ai to strengthen its enterprise agentic-automation capabilities; the deal was expected to close in November 2026.
Tata Trusts, which holds a 66% stake in Tata Sons, proposed merging Tata Electronics Systems Solutions and Tata Consulting Engineers into Tata Sons as part of a reorganisation aimed at taking Tata Sons outside rules applying to NBFCs and core investment companies.
Fortis Healthcare said it was a “complete stranger” to the legal dispute between Daiichi Sankyo and the Singh Brothers and had no involvement in the alleged diversion of the former promoters’ shareholding.
Publishers
18
Articles
7
Reach
25